Tetraphase Pharmaceuticals to Present at BMO Prescriptions for Success Healthcare Conference
December 05 2018 - 6:30AM
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical
company focused on developing and commercializing novel antibiotics
to treat life-threatening multidrug-resistant (MDR) infections,
today announced that President and Chief Executive Officer Guy
Macdonald will present a corporate overview at the BMO
Prescriptions for Success Healthcare Conference on Wednesday,
December 12, 2018 at 9:40 a.m. ET at the Mandarin Oriental Hotel in
New York City.
A live audio webcast of the BMO Prescriptions
for Success Healthcare Conference presentation will be available on
the Company’s website at
https://tphase.gcs-web.com/events-presentations. The archived
presentation will be available for 30 days.
About Tetraphase Pharmaceuticals,
Inc.Tetraphase is a biopharmaceutical company using its
proprietary chemistry technology to create novel antibiotics for
serious and life-threatening bacterial infections, including those
caused by many of the multidrug-resistant bacteria highlighted as
urgent public health threats by the World Health Organization and
the Centers for Disease Control and Prevention. The Company has
created more than 3,000 novel tetracycline compounds using its
proprietary technology platform. Tetraphase's lead product XERAVATM
(eravacycline) is approved for the treatment of complicated
intra-abdominal infections by the U.S. Food and Drug Administration
and the European Medicines Agency. The Company’s pipeline also
includes TP-271 and TP-6076, which are in Phase 1 clinical trials.
Please visit www.tphase.com for more company information.
Media and Investor Contact:Tetraphase
PharmaceuticalsJennifer Viera617-600-7040jviera@tphase.com
Tetraphase Pharmaceuticals (NASDAQ:TTPH)
Historical Stock Chart
From Jul 2024 to Jul 2024
Tetraphase Pharmaceuticals (NASDAQ:TTPH)
Historical Stock Chart
From Jul 2023 to Jul 2024